Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/23/2867607/0/en/Phase-2-RIZE-Study-Sub-Analyses-to-be-Presented-at-the-2024-Pediatric-Endocrine-Society-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/03/06/2841293/0/en/Rezolute-Reports-Validation-of-the-Potential-Use-of-RZ358-for-Treatment-of-Non-Islet-Cell-Tumor-Hypoglycemia-NICTH.html
https://www.globenewswire.com//news-release/2024/02/13/2828647/0/en/Rezolute-Reports-Second-Quarter-Fiscal-2024-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/01/24/2815219/0/en/Rezolute-Expands-Leadership-Team-with-Appointment-of-Daron-Evans-MS-MBA-as-Chief-Financial-Officer.html
https://www.globenewswire.com//news-release/2024/01/23/2814018/0/en/Rezolute-Receives-Innovation-Passport-Designation-from-the-U-K-Innovative-Licensing-and-Access-Pathway-Steering-Group-for-RZ358-in-the-Treatment-of-Hypoglycemia-Due-to-Congenital-H.html
https://www.globenewswire.com//news-release/2023/12/14/2796213/0/en/Rezolute-Initiates-Phase-3-Clinical-Study-for-RZ358-in-Congenital-Hyperinsulinism.html
https://www.globenewswire.com//news-release/2023/12/13/2795495/0/en/Rezolute-Completes-Enrollment-of-its-Phase-2-Study-in-Diabetic-Macular-Edema-DME.html
https://www.globenewswire.com//news-release/2023/11/17/2782535/0/en/Rezolute-to-Participate-in-BTIG-s-3rd-Annual-Ophthalmology-Day.html
https://www.globenewswire.com//news-release/2023/11/13/2779429/0/en/Rezolute-Reports-First-Quarter-Fiscal-2024-Results.html
https://www.globenewswire.com//news-release/2023/10/17/2761459/0/en/Rezolute-Receives-Priority-Medicines-PRIME-Eligibility-from-European-Medicines-Agency-for-Enhanced-Regulatory-Support-of-RZ358-in-Congenital-Hyperinsulinism.html